Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Haemorrhagic shock therapy.

Devashish J Anjaria1, Alicia M Mohr, Edwin A Deitch

  • 1UMDNJ-New Jersey Medical School, Department of Surgery, Newark, NJ 07101, USA.

Expert Opinion on Pharmacotherapy
|April 2, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting bone marrow and plasma exosomal microRNA profiles following trauma.

Surgery·2026
Same author

Population Heterogeneity in Iron Biomarkers by Age, Sex, Menopausal Status, and Race in Healthy U.S. Adults: A Cross-Sectional Analysis from the All of Us Research Program.

Nutrients·2026
Same author

A murine model of sepsis induces age- and sex-specific chromatin remodeling in myeloid-derived suppressor cells.

Frontiers in immunology·2026
Same author

Divergent chromatin remodeling trajectories in CD66b <sup>+</sup> MDSCs distinguishes recovery from chronic critical illness after sepsis.

bioRxiv : the preprint server for biology·2026
Same author

Age- and Sex- Driven Transcriptional and Metabolic Diversity in Myeloid-Derived Suppressor Cells After Mouse Sepsis.

bioRxiv : the preprint server for biology·2025
Same author

Sepsis Induces Age- and Sex-Specific Chromatin Remodeling in Myeloid-Derived Suppressor Cells.

bioRxiv : the preprint server for biology·2025
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Emerging therapies for severe haemorrhagic shock, including advanced haemostatic agents and massive transfusion protocols, show promise. These novel strategies aim to improve survival and outcomes for severely injured patients experiencing major blood loss.

Area of Science:

  • Trauma Care
  • Emergency Medicine
  • Resuscitation Science

Background:

  • Haemorrhagic shock is a leading cause of preventable death in severe trauma.
  • Effective management requires a continuum of care from prehospital to critical care.

Purpose of the Study:

  • To review emerging therapeutic strategies for treating haemorrhagic shock.
  • To synthesize recent advancements in trauma resuscitation.

Main Methods:

  • Literature review of clinical articles published between 1996 and 2007.
  • Focused on therapeutic interventions for haemorrhagic shock.

Main Results:

  • Novel therapies are being developed beyond traditional haemostasis and perfusion.

Related Experiment Videos

  • Key areas include advanced haemostatic agents, hypertonic solutions, and massive transfusion protocols.
  • Blood substitutes and refined damage control principles are also emerging.

    • Conclusions:

    • While haemostasis and perfusion remain critical, new strategies enhance treatment.
    • These advancements offer potential for increased survival and better outcomes in severe haemorrhage.
    • Improved understanding of damage control principles is vital for severely injured patients.